Delivery Order 36C24925D0012-36C24925N0048
Award Date
10/1/24
Potential Completion Date
9/30/29
Potential Value
$2.6M
Federal Agency
Veterans Integrated Service Network 9
Awardee
Pharmalogic Holdings Corp.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lexington, KY 40502, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $396,959.20 firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 9 (VISN 9) to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico. The contract, which has a period of performance from April 2025 to September 2025, is for the procurement of PYLARIFY F-18 piflufolastat, a radiopharmaceutical used for prostate cancer imaging. This award is part of a larger $2,616,322.00 Indefinite...
This is a federal contract award to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, by the U.S. Department of Veterans Affairs (VA). The 5-year contract, with a ceiling value of $469,133.60, is for the delivery of PYLARIFY 18 radiopharmaceutical products used in nuclear medicine diagnostic imaging. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of September 30, 2029. Pharmalogic Holdings Corp. is a for-profit...
The Department of Veterans Affairs, Network Contracting Office 10 awarded a firm-fixed price purchase order contract to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, to supply 200 doses of PYLARIFY F-18 piflufolastat radiopharmaceutical for the imaging of patients with prostate cancer at the Dayton VA Medical Center over a 12-month period. The $721,744.00 ceiling value contract has a performance period from June 17, 2024 to June 16, 2025. This procurement was set aside...
This federal contract award was made by the Veterans Integrated Service Network 23 (VISN 23), a civilian agency that is part of the U.S. Department of Veterans Affairs (VA), to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico. The $200,255.59 firm-fixed-price delivery order contract is for the supply of radiopharmaceuticals and was not set aside for any specific business category. Pharmalogic Holdings Corp. is a for-profit organization that specializes in providing nuclear...
This is a $2,056,970.40 firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The contract is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect and image prostate cancer. The contract has an ultimate completion date of August 31, 2027 and was...
This federal contract award is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The prime contractor is Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc. that specializes in innovative diagnostic imaging agents and targeted oncology therapies. The contract, valued at $124,296.48, was awarded by the Veterans Integrated Service Network 12 (VISN 12)...
This is a firm fixed-price delivery order contract awarded to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The contract, valued at $1,466,705.44, is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The contract has an ultimate completion date of October 31,...
This federal contract award to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, was issued by the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network (VISN) 23. The $45,404.73 firm-fixed-price delivery order is for the provision of single-dose radiopharmaceuticals and generator nuclear medicine products to support nuclear medicine diagnostic imaging procedures at VA medical facilities. This award is part of a larger $2,664,954.52...
This is a firm-fixed price delivery order contract awarded by the Department of Veterans Affairs (VA) to Pharmalogic Holdings Corp., doing business as Pharmalogic Puerto Rico, a for-profit organization. The contract, with a ceiling value of $978,250.00, is for the supply of F18-florbetapir (NeuraCeq) radiopharmaceutical in single-unit doses to support nuclear medicine diagnostic imaging procedures at VA medical facilities. The contract is structured as a Blanket Purchase Agreement (BPA) call and...
This is a federal contract award to Pharmalogic Holdings Corp., a for-profit company based in Boca Raton, Florida, to provide single-dose radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The contract has a ceiling value of $96,546.45 and is a delivery order contract with a firm fixed price. The ultimate completion date is February 28, 2025. This contract is not a set-aside award. Pharmalogic Holdings Corp. specializes in supplying radiopharmaceuticals and related products to...